Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves’ disease after (131)Iodine treatment

Por Zhang, Li-Hua, Li, Jing-Yan, Tian, Qi, Liu, Shuang, Zhang, Hong, Liu, Sheng, Liang, Jiu-Gen, Lu, Xian-Ping, Jiang, Ning-Yi
Publicado no J Radiat Res (2016)

The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats

Por Li, Ping-Ping, Shan, Song, Chen, Yue-Teng, Ning, Zhi-Qiang, Sun, Su-Juan, Liu, Quan, Lu, Xian-Ping, Xie, Ming-Zhi, Shen, Zhu-Fang
Publicado em 2006

Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ

Por Pan, De-Si, Wang, Wei, Liu, Nan-Song, Yang, Qian-Jiao, Zhang, Kun, Zhu, Jing-Zhong, Shan, Song, Li, Zhi-Bin, Ning, Zhi-Qiang, Huang, Laiqiang, Lu, Xian-Ping
Publicado no PPAR Res (2017)

CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Por Zhou, You, Shan, Song, Li, Zhi‐Bin, Xin, Li‐Jun, Pan, De‐Si, Yang, Qian‐Jiao, Liu, Ying‐Ping, Yue, Xu‐Peng, Liu, Xiao‐Rong, Gao, Ji‐Zhou, Zhang, Jin‐Wen, Ning, Zhi‐Qiang, Lu, Xian‐Ping
Publicado no Cancer Sci (2017)